Hisashi Yoshimura revealed that H19 has important roles in pancreatic cancer metastasis, and that inhibition of H19 represents a novel candidate for pancreatic cancer therapy (Yoshimura et al., 2018). This evidence concerns the gene H19 and familial pancreatic carcinoma.